Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test. This test is a diagnostic tool used to detect and differentiate between the four main species of malaria-causing parasites: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae.
Test Details
The Malaria Multiplex (P. Falciparum, P. Vivax, P. Ovale, and P. Malariae) Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic tool used to detect and differentiate between the four main species of malaria-causing parasites: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. This test is based on the detection of RNA (ribonucleic acid) molecules specific to each malaria parasite species.
RNA is extracted from a patient’s blood sample and amplified using a technique called reverse transcription polymerase chain reaction (RT-PCR). This amplification process allows for the detection of even small amounts of parasite RNA. The test utilizes specific primers and probes that target unique regions of the RNA from each malaria parasite species. These primers and probes bind to the target RNA sequences, and if the corresponding parasite species is present in the blood sample, it will produce a positive signal.
The Malaria Multiplex (P. Falciparum, P. Vivax, P. Ovale, and P. Malariae) Multiplex Detection & Differentiation (RNA Detection) Qualitative Test provides qualitative results, meaning it can determine whether a particular malaria parasite species is present in the sample or not. It cannot quantify the parasite load or provide information about the severity of the infection. This test is highly sensitive and specific, allowing for accurate detection and differentiation of the four main malaria parasite species. It is particularly useful in regions where multiple species of malaria parasites coexist, as it helps guide appropriate treatment strategies and control measures.
Test Components
- Price: 1530.0 AED
- Sample Condition: Whole blood, dried spot
Report Delivery
Report delivery for the Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test is as follows:
- 4th Working Day: Email (48 hours)
- On phone: 36 hours
Method
The Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test is performed using the Real Time RT-PCR method.
Test Type
The test type for the Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test is viral.
Doctor
This test is conducted under the supervision of a physician.
Test Department
This test is conducted in the Genetics department.
Pre Test Information
Prior to the test, patients are required to sign a Consent document and bring any clinical history of the patient for Malaria Multiplex (P. Falciparum, P. Vivax, P. Ovale, and P. Malariae) Multiplex Detection & Differentiation (RNA Detection) Qualitative Test.
| Test Name | Malaria Multiplex P. Falciparum P. Vivax P. Ovale and P. Malariae Multiplex Detection and Differentiation RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1530.0 AED |
| Sample Condition | Whole blood,dried spot |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time RT- PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMalaria Multiplex (P. Falciparum, P. Vivax, P. Ovale and P. Malariae Multiplex Detection & Differentiation (RNA Detection) QualitativeTest |
| Test Details |
The Malaria Multiplex (P. Falciparum, P. Vivax, P. Ovale, and P. Malariae) Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic tool used to detect and differentiate between the four main species of malaria-causing parasites: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. This test is based on the detection of RNA (ribonucleic acid) molecules specific to each malaria parasite species. RNA is extracted from a patient’s blood sample and amplified using a technique called reverse transcription polymerase chain reaction (RT-PCR). This amplification process allows for the detection of even small amounts of parasite RNA. The test utilizes specific primers and probes that target unique regions of the RNA from each malaria parasite species. These primers and probes bind to the target RNA sequences, and if the corresponding parasite species is present in the blood sample, it will produce a positive signal. The Malaria Multiplex (P. Falciparum, P. Vivax, P. Ovale, and P. Malariae) Multiplex Detection & Differentiation (RNA Detection) Qualitative Test provides qualitative results, meaning it can determine whether a particular malaria parasite species is present in the sample or not. It cannot quantify the parasite load or provide information about the severity of the infection. This test is highly sensitive and specific, allowing for accurate detection and differentiation of the four main malaria parasite species. It is particularly useful in regions where multiple species of malaria parasites coexist, as it helps guide appropriate treatment strategies and control measures. |
